17 Nov 08 Ferumoxytol Resubmission Designated Complete, Class 1 Response By FDA - Iron Deficiency Anemia In Chronic Kidney Disease Patients

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the U.S. Food and Drug Administration (FDA) has designated the Company’s resubmission to the October 2008 Complete Response letter for its New Drug Application (NDA) for ferumoxytol as a complete, Class 1 response. The FDA has established a December 30, 2008 Prescription Drug User Fee Act (PDUFA) target action date.
(more…)

Tags: Anemia, Chronic Kidney Disease, Disease Patients, Drug Application, Fda, Ferumoxytol, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Iron Anemia, Iron Deficiency, Iron Deficiency Anemia, Nasdaq, Nda, Pharmaceuticals Inc, Prescription Drug, Response Letter, Target Action

07 Nov 08 'Prescription Switching' Would Make Most Patients Unhappy (HealthDay)

HealthDay - THURSDAY, Nov. 6 (HealthDay News) — Most prescription drug users would
be unhappy if one of their medications was switched to another in the same
class without their knowledge or their doctor's approval, a new survey
shows.
(more…)

Tags: Drug Users, Medications, New Survey, Prescription Drug

11 Oct 08 Some depressed patients opt for assisted suicide (Reuters)

Reuters - The results of a survey in Oregon suggest that the Death with Dignity Act enacted in the state in 1997 does not always prevent patients with depression, a treatable condition, from receiving a prescription for a lethal drug.
(more…)

Tags: Assisted Suicide, Death With Dignity, Death With Dignity Act, Depressed Patients, Depression, Prescription Drug, Reuters, Treatable Condition